Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Doxorubicin
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Doctoral Thesis
(6)
+
-
Article / Letter to editor
(5)
+
-
Availability
Open access
(8)
+
-
Some under embargo
(2)
+
-
Metadata Only
(1)
+
-
Creation Date
2023
(2)
+
-
Faculty
Faculty of Science
(3)
+
-
Leiden University Medical Center (LUMC)
(5)
+
-
Collection
Dissertations
(6)
+
-
Medicine / Leiden University Medical Centre (LUMC)
(5)
+
-
Leiden Academic Centre for Drug Research (LACDR)
(2)
+
-
Topic
Doxorubicin
(11)
+
-
Osteosarcoma
(3)
+
-
Anti-cancer
(2)
+
-
Apoptosis
(2)
+
-
Soft tissue sarcoma
(2)
+
-
Transporters
(2)
+
-
Show more
Author
Gelderblom, H.
(3)
+
-
Marreaud, S.
(2)
+
-
Language
en
(11)
+
-
Search results
(1 - 11 of 11)
show grid
show list
save search
Functional study of the human genome
Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters
Case report
Novel insights into old anticancer drugs
Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment
IWR-1, a tankyrase inhibitor, attenuates Wnt/beta-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft
Novel regulators of endosome dynamics, MHCII antigen presentation and chemosensitivity
Osteosarcoma : searching for new treatment options
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogeneti
Understanding immunotherapy and chemotherapy : new way of antigen cross-presentation and novel anti-tumor effects by doxorubicin
Focal adhesion kinase signaling in metastasis and breast cancer treatment